CEBMMS PI
1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- A collaborative analysis of individual participant data from 19 prospective studies assesses circulating Vitamin D and prostate cancer risk
- 2018
- Allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT
- Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age : Data from the malmö preventive project
- A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer
- Quantitative Assessment of Urea In-Solution Lys-C/Trypsin Digestions Reveals Superior Performance at Room Temperature over Traditional Proteolysis at 37 °C.
- Genetic Elucidation of Xg, the last unresolved blood group system
- Reducing WBC background in cancer cell separation products by negative acoustic contrast particle immuno-acoustophoresis
- Targeted proteomics of hip articular cartilage in OA and fracture patients
- A molecular mechanism underlying the P1/P2 phenotypes: allele-selective RUNX1 binding regulates P1 blood group status by transcriptional control of A4GALT
- Structural basis for endotoxin neutralisation and anti-inflammatory activity of thrombin-derived C-terminal peptides